NeuroOne Medical Technologies (NMTC) general counsel Johns received 500,000 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Emily J. Johns (General Counsel at NeuroOne Medical Technologies Corporation, NMTC) reported that they received 500,000 shares on Jun 1, 2025.
- Reporting person
- Johns Emily J.
- Role
- General Counsel
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 1, 2025 | Grant or award (A) | Option to Purchase Common StockOn 500,000 Common Stock1 | +500,000 | - | - | 500,000 direct |
Holdings before and after
- Option to Purchase Common Stock: 0 to 500,000 direct
Footnotes from the filing
- 1. 25% will vest on June 1, 2026, and the remaining 75% will vest in 12 equal quarterly installments on the last day of each quarter beginning on June 30, 2026.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Johns report in this NMTC Form 4?
Emily J. Johns (General Counsel at NeuroOne Medical Technologies Corporation, NMTC) reported that they received 500,000 shares on Jun 1, 2025.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for NMTC
Earlier insider filings at NMTC
- May 23, 2025Business Development Director Christianson Mark sold $5,596 worth of shares (8,981 units at $0.62), decreasing direct ownership by 3% to 271,491 units (SEC Form 4)
- May 21, 2025Business Development Director Christianson Mark sold $7,306 worth of shares (11,019 units at $0.66), decreasing direct ownership by 4% to 280,472 units (SEC Form 4)
- Apr 21, 2025SEC Form 4 filed by Business Development Director Christianson Mark
- Apr 21, 2025SEC Form 4 filed by Chief Technology Officer Mertens Steve
- Apr 21, 2025SEC Form 4 filed by Chief Operating Officer Volker Christopher
Keep researching NMTC
- NMTC insider tradesEvery buy and sale reported by NeuroOne Medical Technologies Corporation officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- NMTC earnings historyPast NeuroOne Medical Technologies Corporation earnings releases, newest first.
- NMTC financial statementsRevenue, profit, cash flow and balance sheet from NeuroOne Medical Technologies Corporation's SEC filings.
Quantisnow market dataNASDAQ
NMTC
NeuroOne Medical Technologies Corporation
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
Get push alerts for NMTC
Full NMTC profile on Quantisnow Follow NMTC and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time